Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

PVLAPVLA
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in Palvella Therapeutics, Inc.

GOLDMAN SACHS GROUP INC holds 201,514 shares of PVLA (Palvella Therapeutics, Inc.), worth $30.8M as of 2026-Q2. The position was increased (+3.8% shares). PVLA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$30.8M

Current Shares

201,514

Total Value Change

+$30.3M

Total Shares Change

+182,461

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
201,514
+3.8%
$30.8M0.0%$152.82
30
2026-Q1
Increased
194,179
+96.3%
$24.2M0.0%$131.51
46
2025-Q4
Decreased
98,935
-58.2%
$10.4M0.0%$99.88
0
2025-Q3
Increased
236,630
+177.3%
$14.8M0.0%$62.25
45
2025-Q2
Increased
85,329
+347.9%
$1.9M0.0%$22.08
42
2025-Q1
New
19,053
-
$533,2930.0%$28.10
34

Other major holders of PVLA: JENNISON ASSOCIATES LLC, BlackRock, Inc., STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used